Beacon Bridge Wealth Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$353K Buy
294
+57
+24% +$58.2K 0.1% 90
2026
Q1
$218K Sell
237
-8
-3% -$8.11K 0.07% 96
2025
Q4
$263K Buy
+245
New +$234K 0.09% 88

Other funds holding LLY

Beacon Bridge Wealth Partners's LLY Position: Q2 2026 in Review

Beacon Bridge Wealth Partners increased its Eli Lilly (LLY) stake by 24% in Q2 2026, buying an estimated $58.2K and bringing the position to 294 shares worth $353K. The position accounts for 0.1% of the portfolio, ranked #90.

Beacon Bridge Wealth Partners first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Beacon Bridge Wealth Partners held 294 shares of Eli Lilly worth $353K as of Q2 2026.
  • Beacon Bridge Wealth Partners bought 57 Eli Lilly shares in Q2 2026, an estimated $58.2K.
  • Eli Lilly made up 0.1% of Beacon Bridge Wealth Partners's portfolio in Q2 2026, its #90 holding.
  • Beacon Bridge Wealth Partners first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Beacon Bridge Wealth Partners's 13F filing for Q2 2026, filed 5 Aug 2026.